Dedline: Abstract submission: Friday, August 2, 2024

TFOS 2024 Conference - Platform sessions

Thursday, October 31
Opening remarks - Stefano Bonini (Italy)
Conference Address
Moderator – Stefano Bonini (Italy)
The future of tear film and ocular surface research – Mark DP Willcox (Australia)

Session 1. Ocular surface disease: What we do to ourselves
Moderators: Arturo Grau (Chile), Bridgitte Shen Lee (USA)
Contact lenses – Alex Hui (Canada)
Cosmetics - Rachna Murthy (UK)
Digital eye strain - Laura Downie (Australia)
Environmental conditions – Monica Alves (Brazil)
Nutrition - Marc Labetoulle (France)
Lifestyle – Michael TM Wang (New Zealand)

Session 2. East, West, North, South: Impact of geographic region and ethnicity on the prevalence and management of ocular surface disease
Moderators - Stefano Barabino (Italy), Jutta Horwath-Winter (Austria)
Fuchs endothelial corneal dystrophy and corneal endothelial diseases - Jodhbir Mehta (Singapore)
Keratoconus – Farhad Hafezi (Switzerland)
Dry eye disease - Jelle Vehof (The Netherlands)
Ocular Allergy – Andrea Leonardi (Italy)
Uncorrected refractive error – Lixia Lou (China)
Pterygium - José Gomes (Brazil)

Session 3. Models and biomarkers for ocular surface disease
Moderators – Benjamin Sullivan (USA), Piera Versura (Italy)
Role of mitochondria in dry eye disease - Wei Chen (China)
Ectodysplasin A mutation: A model for meibomian gland dysfunction and corneal epithelial abnormalities - Shangkun Ou (China)
Development and application of a human corneal endothelial cell model - Francisco Bandeira e Silva (Brazil)
Intrinsic disorder in the human tear proteome -David Taylor Gonzalez (USA)
Tear film microRNAs as potential biomarkers – Ashok Sharma (USA)
Biochemical, molecular and genetic biomarkers in the tear film of glaucoma patients - Maria D. Pinazo-Durán (Spain)

Session 4. Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
Moderators - Sihem Lazreg (Algeria), Tor Paaske Utheim (Norway)
Epidemiology and pathophysiology of glaucoma - Gus Gazzard (UK)
Prevalence of, and risk factors for, ocular surface disease in glaucoma patients - Elisabeth Messmer (Germany)
Adverse effects of active ingredients in glaucoma medications on the ocular surface, adnexa, nasolacrimal duct and periorbital area - Raul E Ruiz-Lozano (Mexico)
Adverse effects of additives in glaucoma medications - Miriam Kolko (Denmark)
Management of ocular surface disease in glaucoma patients - Christophe Baudouin (France)
Management of glaucoma in ocular surface disease patients - Barbara Cvenkel (Slovenia)

Poster Session I
Moderators – Enesa Begovic (Bosnia), Giulio Ferrari (Italy)

TFOS i2 Innovation Showcase (early evening)
Moderator – Jonathan Roos (UK)
Introduction (4 minutes) – Amy Gallant Sullivan (France)
Startup company presentations – each 3 minutes, 2 minutes discussion

Friday, November 1
Special Session. Seeing differently: The meaning of blindness
Moderators – Esen Akpek (USA), Gerd Geerling (Germany),
Seeing differently: A blind person's perspective on the meaning of blindness - Deborah Tramentozzi (Italy)
Seeing differently: A clinician's perspective on the meaning of blindness – Lotfi Merabet (USA)

Session 5. Meibomian gland dysfunction update
Moderators - Kyung-Sun Na (South Korea), Kelly Nichols (USA)
Prevalence of meibomian gland dysfunction in adults – Fiona Stapleton (Australia)
Prevalence of meibomian gland atrophy in children – Preeya Gupta (USA)
Hyperlipidemia induces meibomian gland dysfunction – Wei Li (China)
Advances in meibography for the diagnosis of meibomian gland dysfunction - Reiko Arita (Japan)
Intense pulsed light therapy for meibomian gland dysfunction and dry eye disease - José Benitez del Castillo Sanchez (Spain)
Hypoxia: A breath of fresh air for optimal meibomian gland function - Yang Liu (China)

Session 6. TFOS Dry Eye Workshop III  
Moderators - Friedrich Paulsen (Germany), David A Sullivan (USA)
Introduction - Victor L Perez Quinones (USA)
Definition, classification and diagnosis of dry eye disease - James Wolffsohn (UK)
Management and therapy of dry eye disease - Lyndon Jones (Canada)
Delphi panel initiative - Jennifer Craig (New Zealand)

Session 7. Did you know?
Moderators – Pasquale Aragona (Italy), Jesús Merayo-Lloves (Spain)
Convergence of artificial intelligence and microelectronics with ocular surface biology and disease – Dimitri Azar (USA)
Disruptive contact lens technologies - Philip Morgan (UK)
Human ocular mucins and beyond – Pablo Argueso (USA)
Impact of oxidative stress on the lacrimal functional unit - Eduardo Rocha (Brazil)
Obstructive sleep apnea affects lacrimal gland function - Zuguo Liu (China)
Novel role of lymphatic vessels in the pathogenesis of ocular surface disease - Claus Cursiefen (Germany)

Session 8. New insights into the pathophysiology and management of catastrophic ocular surface diseases
Moderators – Alejandro Navas (Mexico), Kyung Chul Yoon (South Korea)
Corneal ulcers (e.g. due to bacterial, fungal and parasitic infections) – James Chodosh (USA)
Improving Outcomes in Acute Ocular Burns - Geetha Iyer (India)
Graft versus host disease - Victor L Perez Quinones (USA)
Stevens-Johnson syndrome/toxic epidermal necrolysis - Hajirah Saeed (USA)
Neurotrophic keratopathy – Harminder Dua (UK)
Ocular surface tumors – Carol L Karp (USA)

Poster Session II
Moderators – Heiko Pult (Germany), Adriana Stanila (Romania)

Saturday, November 2
Session 9 Limbal stem cell deficiency
Moderators – Paolo Rama (Italy), Virender Sangwan (India)
The promise and challenge of stem cells in regenerative medicine - Graziella Pellegrini (Italy)
Homeostasis of the corneal stem cell niche from a single cell analysis prospective - Majlinda Lako (UK)
Mapping the limbal stem cell niche and limbal stem cell deficiency in animal models – Nick Di Girolamo (Australia)
Diagnosis and staging of limbal stem cell deficiency - Sophie Deng (USA)
Advances in the treatment of limbal stem cell deficiency - Sayan Basu (India)
Bioengineered cornea construct - May Griffith (Canada)

Session 10. Eye surgery, intravitreal injections and iatrogenic ocular surface disease
Moderators: Christina Grupcheva (Bulgaria), Mohamed Shafik Shaheen (Egypt)
Refractive surgery-induced dry eye disease - Ikuko Toda (Japan)
Cataract surgery-induced dry eye disease - Edoardo Villani (Italy)
An algorithm for the preoperative diagnosis and treatment of ocular surface disease in refractive surgery patients – Christopher E Starr (USA)
Iatrogenic ocular surface diseases after surgery for ocular tumors - Giuseppe Giannaccare (Italy)
Impact of posterior segment surgery on the ocular surface - Marco Coassin (Italy)
Impact of intravitreal injections on the ocular surface - Corinne Dot (France)

Session 11. What a nerve!
Moderators – Carlos Belmonte (Spain), Murat Dogru (Japan/Australia)
What is neuropathic pain, and what are the underlying mechanisms? – Anat Galor (USA)
Management of neuropathic pain – Pedram Hamrah (USA)
An experimental model of neuro-immune interactions in the eye: Corneal sensory nerves and resident dendritic cells - Juana Gallar (Spain)
Corneal nerves and their role in dry eye pathophysiology - Jeremias Galletti (Argentina)
Corneal neurotization: Indications, surgical techniques and outcomes - Roberto Pineda (USA)

Session 12. The microbiome: Do we need to keep an eye on it?
Moderators – Hiroshi Eguchi (Japan), Marc Labetoulle (France)
New insights into the identification and role of the microbiome – Marcus C de Goffau (UK)
Exposomes, the microbiome, and ocular surface disease - Louis Tong (Singapore)
Ocular surface microbiota in keratoconus - Carlos Rocha-de-Lossada (Spain)
Ocular microbiome changes in dry eye disease - Jerome Ozkan (Australia)
Role of nerve-associated ion channels in resisting bacterial adhesion to the corneal surface – Suzanne Fleiszig (USA)
The gut-eye-lacrimal gland-microbiome axis in Sjögren syndrome - Cintia de Paiva (USA)

Closing remarks - David A Sullivan (USA)

Poster Session III
Moderators – Paul Karpecki (USA), Cecilia Marini (Argentina)

Registration required. Please contact the organizer for further information.